Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
about
Pediatric AML: From Biology to Clinical ManagementMolecular cytogenetic studies characterizing a novel complex karyotype with an uncommon 5q22 deletion in childhood acute myeloid leukemiaA recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children's Oncology Group.
P2860
Outcome of pediatric patients with acute myeloid leukemia (AML) and -5/5q- abnormalities from five pediatric AML treatment protocols: a report from the Children's Oncology Group.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Outcome of pediatric patients ...... the Children's Oncology Group.
@en
Outcome of pediatric patients with acute myeloid leukemia
@nl
type
label
Outcome of pediatric patients ...... the Children's Oncology Group.
@en
Outcome of pediatric patients with acute myeloid leukemia
@nl
prefLabel
Outcome of pediatric patients ...... the Children's Oncology Group.
@en
Outcome of pediatric patients with acute myeloid leukemia
@nl
P2093
P2860
P356
P1476
Outcome of pediatric patients ...... the Children's Oncology Group.
@en
P2093
Alan S Gamis
Betsy Hirsch
Beverly J Lange
Donna L Johnston
Robert B Gerbing
Susana C Raimondi
Todd A Alonzo
William G Woods
Yaddanapudi Ravindranath
P2860
P304
P356
10.1002/PBC.24573
P577
2013-08-30T00:00:00Z